SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+2.0%
5Y CAGR+3.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+2.0%/yr
vs +8.7%/yr prior
5Y CAGR
+3.6%/yr
Consistent
Acceleration
-6.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $115.58B | +1.0% |
| 2024 | $114.42B | +1.1% |
| 2023 | $113.19B | +4.1% |
| 2022 | $108.76B | +18.0% |
| 2021 | $92.19B | -4.8% |
| 2020 | $96.80B | +15.5% |
| 2019 | $83.84B | +7.8% |
| 2018 | $77.77B | -6.0% |
| 2017 | $82.70B | +29.9% |
| 2016 | $63.66B | - |